John Jumper departs DeepMind for Anthropic

John Jumper announced on X that he is leaving Google DeepMind after nearly nine years to join Anthropic, per The Decoder and Times of India. In the social post Jumper wrote, "The entire GDM team taught me so much about how to do great science," and "GDM is a special place, and I'll still be excited to hear about what amazing things they discover next," per reporting on his public post. Coverage states that Jumper said he will take a short break to recharge before starting at Anthropic, and that he has not publicly disclosed his role at the company.

Public reporting identifies AlphaFold as the landmark system Jumper co-led that predicts protein 3D structure from amino acid sequence. Times of India reports AlphaFold now offers over 200 million protein structure predictions, and FourWeekMBA cites AlphaFold usage by more than 2 million researchers across 190 countries. The 2024 Nobel Prize in Chemistry awarded to Jumper and Demis Hassabis for AlphaFold is consistently referenced in coverage as the scientific milestone underlying Jumper's prominence.

Multiple outlets frame Jumper's move as part of a wider flow of senior AI talent toward well-funded startups. The Decoder notes this follows Gemini co-lead Noam Shazeer leaving for OpenAI, reflecting a broader pattern of senior DeepMind researchers departing. FourWeekMBA reports that Anthropic has been expanding an "AI-for-science" footprint in 2026, mentioning wet labs, agent-in-biology research, and partnerships with research institutions, and positions Jumper's arrival against that backdrop. A Nobel laureate with deep domain experience in computational biology joining a safety-focused frontier lab raises the visibility of cross-disciplinary AI-for-science work.

Public signals to follow include an official role announcement from Anthropic, any authored papers or preprints from Jumper after his joining, changes in Anthropic's partnerships with academic or life-science institutions, and disclosure of lab openings or capabilities that intersect with protein design. Reporting so far has not detailed compensation, hiring scope, or product roadmaps; Jumper's public post and downstream coverage both note those specifics were not disclosed.

Demis Hassabis wrote on X: "Thanks John for an extraordinary partnership and wonderful collaboration over the past 9 years! What we achieved with AlphaFold changed the world, and showed the field what was possible with AI for science and medicine, lighting the way for how AI can benefit humanity." This quote is drawn from Hassabis's public X post, confirmed by multiple outlets.

This is a high-profile individual move with clear symbolic weight for the intersection of large-model AI and life-science applications. Reported facts are limited to the announcement, the published quotes, and publicly available descriptions of AlphaFold's impact; practitioners should treat operational or strategic implications as open until Anthropic or Jumper publish further details.